Navigation Links
Dr. Sheldon Pinnell, The Founding Father Of Topical Antioxidants, Leading Scientist Behind SkinCeuticals, And Chief Emeritus Of The Division Of Dermatology At Duke University, Dies At 76
Date:7/12/2013

NEW YORK, July 12, 2013 /PRNewswire/ -- Dr. Sheldon Pinnell, an internationally eminent scientist, dermatologist, leading scientist behind L'Oreal-owned SkinCeuticals, and J. Lamar Callaway Professor Emeritus of Dermatology and Chief Emeritus of the Division of Dermatology at Duke University, passed away peacefully in Durham, North Carolina on Thursday, July 4, 2013 just as the fireworks began to sparkle in celebration of Independence Day. He was 76.

(Photo:  http://photos.prnewswire.com/prnh/20130712/NY45730)

Dr. Pinnell's investigative research has changed the way the world uses topical antioxidants today.  As the founding father of topical antioxidants, he was the first to patent a stable form of vitamin C proven through peer-reviewed research to effectively penetrate skin, delivering eight times the skin's natural antioxidant protection.

Before helping to shape the cosmeceutical industry, Dr. Sheldon Pinnell led major advances in the understanding of skin biology and the pathogenesis of skin diseases. Early in his career, he made seminal contributions to the understanding of Ehlers-Danlos Syndrome and the role of vitamin C in collagen biosynthesis. Dr. Pinnell has been globally recognized for his contributions to science and skincare, most recently receiving an honorary membership to the Society for Investigative Dermatology. 

Over his lifetime, he also received numerous medical and scientific awards including The Best Doctors in America, The International Who's Who in Medicine, Who's Who in Science and Engineering, and Who's Who in America. Dr. Pinnell has published more than 200 scientific articles in peer-reviewed journals on dermatology topics such as photoaging, collagen synthesis, UV protection, topical vitamin C, and other antioxidants.  Dr. Pinnell also authored approximately 20 book chapters and holds ten patents.

"It is our greatest privilege to have been able to help Dr. Pinnell bring his discovery of topical antioxidants to life.  Prior to the introduction of topical vitamin C in the early 1990s, skincare professionals were largely limited to sunscreens to protect against the deleterious effects of the sun.  It was Dr. Pinnell who gave the medical community the confidence to transform the approach to at-home skincare.  We are fortunate to have known Dr. Pinnell as a scientist, a family man, and a dear friend. His life lessons and infectious spirit will remain with us forever," said SkinCeuticals Co-Founders, Alden Pinnell and Russell Moon.

"We are honored to have had the chance to know and work with Dr. Pinnell over the years.  It was his breakthrough research that propelled the use of topical antioxidants within the skincare industry. Today, topical antioxidants are widely recognized as an essential component for maintaining and protecting healthy skin.  Most US dermatologists recommend that patients incorporate an antioxidant into their daily skincare routine. Everything he has taught us, as well as his passion for discovery, will continue to live on daily through all of us here at SkinCeuticals. I personally have grown and learned an enormous amount from Dr. Pinnell, and he will be dearly missed," said SkinCeuticals Global General Manager, Marc Toulemonde.

"Dr. Pinnell's philosophy and dedication to advancing science in the cosmeceutical landscape is unlike any we have ever seen, and he remains an inspiration for us today.  It is our esteemed privilege to have had the opportunity to learn from the 'Founding Father of Topical Antioxidants' and introduce a range of products that changed the way we care for our skin globally," said Brigitte Liberman, World Wide President, L'Oreal Active Cosmetic Division.

A graduate of Duke University's Trinity College, Dr. Pinnell earned his medical degree at Yale University and trained at the University of Minnesota Hospital, the National Institutes of Health, Massachusetts General Hospital, and Max Planck Institute for Biochemistry in West Germany. Dr. Pinnell earned his Bachelor of Arts degree in Chemistry at Duke University, where he graduated with Phi Beta Kappa academic honors.

Dr. Pinnell returned to Duke University in 1973 as an associate professor and investigator for the Howard Hughes Medical Institute at the Department of Medicine.  A visionary leader, Dr. Pinnell developed and implemented major strategic initiatives that facilitated the growth and prominence of Duke University's Division of Dermatology and culminated in the establishment of the nationally-recognized Department of Dermatology in 2009. He held the office of Chief of Dermatology for 15 years and retired in 2010 after 37 years of service. During his tenure, he trained over 100 residents, 22 research fellows, and left a legacy of 22 prominent dermatologists, including seven current department chairs, residency program directors, and associate department and vice chairs. Dr. Pinnell also served as a diplomat of the American Board of Dermatology and a member of the American Academy of Dermatology.

"Dr. Pinnell set the highest standard in teaching and research, and his mentorship provided me with the tools necessary to pursue my professional goals. We have lost a true mentor and dear friend," said Tina Alster, M.D., Director, Washington Institute of Dermatologic Laser Surgery Clinical Professor.

"Dr. Pinnell had an energy and enthusiasm for life and a knowledge of dermatology that was second to none. He will be missed by his many colleagues and by dermatologists globally," said Jean Krutmann, M.D., Professor of Dermatology and Environmental Medicine at the Heinrich-Heine-Universitat Dusseldorf.

Dr. Pinnell was accomplished in so many ways, but most particularly he would like to be remembered as a loving husband, father, grandfather, and ardent Duke Blue Devil fan. Dr. Pinnell is survived by his wife, Dr. Doren Madey Pinnell; three sons, Kevin, Alden, and Tyson; and five grandchildren.

A small, private ceremony was held on Monday, July 8th, in Duke University gardens. Later this year, a celebration of his life will be held at the Duke University Chapel, in conjunction with the dedication of the Pinnell Center for Investigative Dermatology. In lieu of flowers, contributions in Dr. Pinnell's honor may be made to Duke University (PO Box 90581, Durham, NC 27701). Contributions may be designated for the Pinnell Center for Investigative Dermatology, or for Duke Athletics, the Sarah P Duke Memorial Gardens, and/or Nasher Museum of Art.


'/>"/>
SOURCE SkinCeuticals
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Managed Health Care Associates, Inc. (MHA) Announced as Founding Member Sponsor of The National Association of Specialty Pharmacy (NASP)
2. Get Dad a Checkup for Fathers Day
3. Intermountain Medical Center Uses SynCardia Total Artificial Heart to Bridge 31-Year-Old Father to a Heart Transplant
4. Independent Pharmacy Cooperative to Distribute Promescent, Topical Medication for Premature Ejaculation
5. Creabilis Announces Headline Results of its Phase 2b Trial of Topical TrkA Kinase Inhibitor CT327
6. Absorption Pharmaceuticals to Receive Patent for Premature Ejaculation Topical Medication
7. Anterios, Inc., Announces Corporate Financing To Further Clinical Development Of Its Topical Botulinum Product
8. Creabilis Awarded Prestigious European Commission FP7 Grant to Further Develop its LSE Topical-by-Design Technology
9. Topokine Acquires Exclusive Rights to Revolutionary Technology for Manufacturing Topical Fat-Reducing Medications
10. Novans SB204 Could Be First Topical Sebum Inhibitor
11. Imprimis Announces Successful Results from its Pharmacokinetic Study for its Impracor Topical NSAID
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)...  LivaNova, PLC, Hersteller des VNS-Therapie ® ... Titel „Epilepsy Around the World" (Epilepsie auf ... gegenüber ein größeres Bewusstsein gefördert werden soll ... Epilepsie auf dem Internationalen Epilepsietag zu einem ... der neuen Infografik sollen wichtige Statistiken zur ...
(Date:2/5/2016)... Calif. , Feb. 5, 2016  Syneron ... global aesthetic device company, announced today that ... Candela North America, is scheduled to participate in ... Healthcare Conference on February 11, 2016 in ... will allow institutional investors to meet with the ...
(Date:2/5/2016)... 5, 2016  Aralez Pharmaceuticals Inc. ("Aralez") today announced ... ("POZEN") and Tribute Pharmaceuticals Canada Inc. ("Tribute") following approval of ... Tribute. The combined company will operate under Aralez Pharmaceuticals ... in Canada , Ireland ... . Under the terms of the Agreement and Plan ...
Breaking Medicine Technology:
(Date:2/5/2016)... FL (PRWEB) , ... February 05, 2016 , ... ... the largest domestic franchisees of Popeyes Louisiana Kitchen restaurants, launched the 14th annual ... awareness for kids and adults with muscular dystrophy, ALS and related diseases that ...
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President ... have signed a joint enrollment and degree completion agreement. The agreement, which ... baccalaureate degrees at FHU|Dickson. , The agreement allows students to be jointly ...
(Date:2/5/2016)... ... February 05, 2016 , ... US Sports Camps , official operators of ... direct high-performance kids yoga training. ChildLight Yoga Studio is centrally situated in the picturesque ... , ChildLight Yoga Studio founder Lisa Flynn expresses her excitement, “We are thrilled to ...
(Date:2/5/2016)... ... February 05, 2016 , ... Regular gym users know the routine: each ... longer to access the treadmills. It’s a predictable trend. After the excesses of November ... get in shape by joining gyms, starting new walking or running routines, or signing ...
(Date:2/5/2016)... WA (PRWEB) , ... February 05, 2016 , ... ... firm, ranked #3 in the 2015 Best in KLAS: Software & Services for ... The annual Best in KLAS report independently ranks vendor performance by healthcare executives, ...
Breaking Medicine News(10 mins):